You are here

  • Home
  • Archive
  • Volume 30, Issue 12
  • PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer

Article metrics

Article menu

Download PDFPDF

Clinical trial
PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer

 

Online download statistics by month:

Online download statistics by month: October 2020 to April 2024

AbstractFullPdf
Oct 2020526505192
Nov 2020513505227
Dec 202010211016227
Jan 2021678661219
Feb 2021480476112
Mar 2021425422135
Apr 2021462452167
May 2021419414142
Jun 2021318315155
Jul 202120920673
Aug 2021203200125
Sep 2021171170109
Oct 2021218217133
Nov 2021221218124
Dec 202120821091
Jan 2022197210119
Feb 202215316386
Mar 2022252266146
Apr 202217117789
May 2022214212134
Jun 202218418997
Jul 202230430595
Aug 2022224230124
Sep 2022250245109
Oct 2022244241125
Nov 2022274274125
Dec 202221821399
Jan 2023274261106
Feb 2023279276120
Mar 2023368366129
Apr 2023270260123
May 202319718790
Jun 2023214210120
Jul 2023247241113
Aug 2023350345156
Sep 2023279269112
Oct 2023300287130
Nov 2023317315125
Dec 2023300272116
Jan 2024232223132
Feb 2024392375140
Mar 2024442436247
Apr 2024239238119
Total13457132735657